Intuitive Surgical, Inc. (NASDAQ:ISRG) Shares Sold by USA Financial Formulas

USA Financial Formulas decreased its position in Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) by 47.4% in the fourth quarter, according to its most recent Form 13F filing with the SEC. The firm owned 2,348 shares of the medical equipment provider's stock after selling 2,115 shares during the period. USA Financial Formulas' holdings in Intuitive Surgical were worth $1,226,000 at the end of the most recent quarter.

Other hedge funds have also made changes to their positions in the company. Godsey & Gibb Inc. grew its holdings in Intuitive Surgical by 140.0% during the 3rd quarter. Godsey & Gibb Inc. now owns 60 shares of the medical equipment provider's stock worth $29,000 after acquiring an additional 35 shares in the last quarter. MidAtlantic Capital Management Inc. bought a new position in shares of Intuitive Surgical in the 3rd quarter worth $33,000. Mark Sheptoff Financial Planning LLC purchased a new stake in shares of Intuitive Surgical during the 2nd quarter worth $37,000. Capital Performance Advisors LLP bought a new stake in Intuitive Surgical during the third quarter valued at about $38,000. Finally, DT Investment Partners LLC grew its stake in Intuitive Surgical by 80.0% in the third quarter. DT Investment Partners LLC now owns 81 shares of the medical equipment provider's stock valued at $40,000 after purchasing an additional 36 shares during the last quarter. 83.64% of the stock is currently owned by hedge funds and other institutional investors.

Insider Buying and Selling at Intuitive Surgical

In related news, SVP Mark Brosius sold 2,128 shares of Intuitive Surgical stock in a transaction that occurred on Tuesday, October 22nd. The stock was sold at an average price of $515.00, for a total transaction of $1,095,920.00. Following the completion of the transaction, the senior vice president now directly owns 273 shares in the company, valued at approximately $140,595. This trade represents a 88.63 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, insider Jamie Samath sold 22,903 shares of the business's stock in a transaction that occurred on Friday, November 8th. The shares were sold at an average price of $525.00, for a total value of $12,024,075.00. Following the completion of the transaction, the insider now directly owns 8,757 shares of the company's stock, valued at $4,597,425. The trade was a 72.34 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last quarter, insiders sold 48,190 shares of company stock worth $25,012,927. Insiders own 0.80% of the company's stock.

Intuitive Surgical Trading Up 0.5 %

Shares of ISRG stock traded up $2.67 during trading hours on Thursday, hitting $582.78. The company's stock had a trading volume of 1,340,112 shares, compared to its average volume of 1,569,929. The stock has a market cap of $207.57 billion, a PE ratio of 93.77, a price-to-earnings-growth ratio of 4.66 and a beta of 1.39. Intuitive Surgical, Inc. has a 12-month low of $355.17 and a 12-month high of $585.50. The company has a 50 day moving average of $537.05 and a 200 day moving average of $496.50.

Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last posted its earnings results on Thursday, October 17th. The medical equipment provider reported $1.56 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $1.24 by $0.32. The company had revenue of $2.04 billion during the quarter, compared to the consensus estimate of $2.01 billion. Intuitive Surgical had a net margin of 28.51% and a return on equity of 13.41%. As a group, analysts anticipate that Intuitive Surgical, Inc. will post 5.45 earnings per share for the current fiscal year.

Wall Street Analyst Weigh In

Several analysts have commented on the stock. Oppenheimer reissued a "market perform" rating on shares of Intuitive Surgical in a research report on Friday, October 18th. Robert W. Baird raised their target price on shares of Intuitive Surgical from $503.00 to $565.00 and gave the company an "outperform" rating in a research note on Thursday, October 17th. Raymond James upped their price target on Intuitive Surgical from $500.00 to $540.00 and gave the stock an "outperform" rating in a research report on Monday, October 14th. BTIG Research raised their price objective on Intuitive Surgical from $535.00 to $561.00 and gave the stock a "buy" rating in a research report on Tuesday, November 26th. Finally, Mizuho upped their target price on Intuitive Surgical from $440.00 to $500.00 in a research report on Thursday, October 17th. One equities research analyst has rated the stock with a sell rating, four have assigned a hold rating and fifteen have issued a buy rating to the company. According to data from MarketBeat, the stock has an average rating of "Moderate Buy" and an average target price of $554.17.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.